HIV, HCV co-immune vaccine manufacturing pharmaceutical company, contact
- 작성자
- 김덕봉
- 이메일
- ker0404@gmail.com
- 작성일
- 2011-10-19
- 조회수
- 366
Please understand the following points.
Blood spread the virus of human infection and progression of disease and the many side effects, loss of national wealth and human damage is inevitable as early as possible a real mission of a human race have to do is resolve.
I go for a B-type hepatitis, 30 years was a tough day.
Sanya in South Korea with the use of natural objects in the wild wanchihan hepatitis case.
Cured of the blood test evidence to guide the activity table.
Name of test unit tests geomsachi
HBsAg Neg .0, 05 Neg 0.05 lU / mL
Anti-HBc Pos (11.64) Neg 1. 0
Anti-HBs Pos (11.8) Neg 10.0 mlU / mL
Carefully check the above items are checked yeokgapyojung.
B-type hepatitis core antigen hangwonjung HBc antigen in the progression of an infection when a blood test can detect, but
Only in the liver cells to determine whether its existence core antigen, or
After cure of hepatitis B antibodies in a blood test is to take a look at.
Using this antibody HIV, HCV vaccine production project, return to start from pharmaceutical companies, research institutions, joint research with academics suggests.
Whether the potential for the manufacture of vaccines gonggeuphu antibody blood is approximately 3-6 months time be sufficient to draw conclusions and
Since hepatitis, the treatment of immune deficiency disease is expected to pursue a project on water.
We disagree pharmaceutical companies, research institutes, etc. are expected to adjust the schedule of the future,
Related to a series of plans to offer your comments.
For the above possible - because security is required,
Needs related to your cooperation and should be used with a thorough follow-up.
Thank you.
ker0404@gmail.com
